Penumbra, Inc. (PEN)
NYSE: PEN · Real-Time Price · USD
267.56
-2.06 (-0.76%)
At close: Mar 28, 2025, 4:00 PM
270.00
+2.44 (0.91%)
Pre-market: Mar 31, 2025, 8:00 AM EDT
Penumbra Market Cap
Penumbra has a market cap or net worth of $10.31 billion as of March 31, 2025. Its market cap has increased by 14.07% in one year.
Market Cap
10.31B
Enterprise Value
10.19B
1-Year Change
14.07%
Ranking
Category
Stock Price
$267.56
Market Cap Chart
Since September 18, 2015, Penumbra's market cap has increased from $1.23B to $10.31B, an increase of 736.27%. That is a compound annual growth rate of 24.96%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 28, 2025 | 10.31B | 13.07% |
| Dec 31, 2024 | 9.11B | -6.12% |
| Dec 29, 2023 | 9.71B | 14.91% |
| Dec 30, 2022 | 8.45B | -21.29% |
| Dec 31, 2021 | 10.73B | 68.92% |
| Dec 31, 2020 | 6.35B | 10.79% |
| Dec 31, 2019 | 5.74B | 36.03% |
| Dec 31, 2018 | 4.22B | 32.02% |
| Dec 29, 2017 | 3.19B | 58.19% |
| Dec 30, 2016 | 2.02B | 25.52% |
| Dec 31, 2015 | 1.61B | 30.52% |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 738.61B |
| UnitedHealth Group | 472.03B |
| Johnson & Johnson | 394.52B |
| AbbVie | 363.15B |
| Novo Nordisk | 305.46B |
| AstraZeneca | 229.16B |
| Abbott Laboratories | 226.88B |
| Merck & Co. | 225.40B |